pubmed-article:15351399 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:15351399 | lifeskim:mentions | umls-concept:C1257890 | lld:lifeskim |
pubmed-article:15351399 | lifeskim:mentions | umls-concept:C0596901 | lld:lifeskim |
pubmed-article:15351399 | lifeskim:mentions | umls-concept:C0018670 | lld:lifeskim |
pubmed-article:15351399 | lifeskim:mentions | umls-concept:C0205147 | lld:lifeskim |
pubmed-article:15351399 | lifeskim:mentions | umls-concept:C0596902 | lld:lifeskim |
pubmed-article:15351399 | lifeskim:mentions | umls-concept:C0038477 | lld:lifeskim |
pubmed-article:15351399 | lifeskim:mentions | umls-concept:C0243071 | lld:lifeskim |
pubmed-article:15351399 | lifeskim:mentions | umls-concept:C1260969 | lld:lifeskim |
pubmed-article:15351399 | lifeskim:mentions | umls-concept:C0813983 | lld:lifeskim |
pubmed-article:15351399 | lifeskim:mentions | umls-concept:C0211726 | lld:lifeskim |
pubmed-article:15351399 | pubmed:issue | 19 | lld:pubmed |
pubmed-article:15351399 | pubmed:dateCreated | 2004-9-7 | lld:pubmed |
pubmed-article:15351399 | pubmed:abstractText | A new series of anandamide and N-oleoylethanolamine analogs, most of which with aromatic moieties in the head group region, has been synthesized and evaluated as inhibitors of anandamide uptake. Some of them efficaciously inhibit the uptake process with K(i) values in the low micromolar range (2.4-21.2microM). Strict structural requisites are needed to observe a significant inhibition and in no case inhibition of fatty acid amidohydrolase overlaps with inhibition of anandamide uptake. | lld:pubmed |
pubmed-article:15351399 | pubmed:language | eng | lld:pubmed |
pubmed-article:15351399 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15351399 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:15351399 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15351399 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15351399 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15351399 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15351399 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15351399 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15351399 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15351399 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15351399 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15351399 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15351399 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15351399 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15351399 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:15351399 | pubmed:month | Oct | lld:pubmed |
pubmed-article:15351399 | pubmed:issn | 0968-0896 | lld:pubmed |
pubmed-article:15351399 | pubmed:author | pubmed-author:MoreraEnricoE | lld:pubmed |
pubmed-article:15351399 | pubmed:author | pubmed-author:OrtarGiorgioG | lld:pubmed |
pubmed-article:15351399 | pubmed:author | pubmed-author:NalliMarianna... | lld:pubmed |
pubmed-article:15351399 | pubmed:author | pubmed-author:Di... | lld:pubmed |
pubmed-article:15351399 | pubmed:author | pubmed-author:LigrestiAless... | lld:pubmed |
pubmed-article:15351399 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:15351399 | pubmed:day | 1 | lld:pubmed |
pubmed-article:15351399 | pubmed:volume | 12 | lld:pubmed |
pubmed-article:15351399 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:15351399 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:15351399 | pubmed:pagination | 5161-9 | lld:pubmed |
pubmed-article:15351399 | pubmed:dateRevised | 2008-11-21 | lld:pubmed |
pubmed-article:15351399 | pubmed:meshHeading | pubmed-meshheading:15351399... | lld:pubmed |
pubmed-article:15351399 | pubmed:meshHeading | pubmed-meshheading:15351399... | lld:pubmed |
pubmed-article:15351399 | pubmed:meshHeading | pubmed-meshheading:15351399... | lld:pubmed |
pubmed-article:15351399 | pubmed:meshHeading | pubmed-meshheading:15351399... | lld:pubmed |
pubmed-article:15351399 | pubmed:meshHeading | pubmed-meshheading:15351399... | lld:pubmed |
pubmed-article:15351399 | pubmed:meshHeading | pubmed-meshheading:15351399... | lld:pubmed |
pubmed-article:15351399 | pubmed:meshHeading | pubmed-meshheading:15351399... | lld:pubmed |
pubmed-article:15351399 | pubmed:meshHeading | pubmed-meshheading:15351399... | lld:pubmed |
pubmed-article:15351399 | pubmed:meshHeading | pubmed-meshheading:15351399... | lld:pubmed |
pubmed-article:15351399 | pubmed:meshHeading | pubmed-meshheading:15351399... | lld:pubmed |
pubmed-article:15351399 | pubmed:meshHeading | pubmed-meshheading:15351399... | lld:pubmed |
pubmed-article:15351399 | pubmed:meshHeading | pubmed-meshheading:15351399... | lld:pubmed |
pubmed-article:15351399 | pubmed:meshHeading | pubmed-meshheading:15351399... | lld:pubmed |
pubmed-article:15351399 | pubmed:meshHeading | pubmed-meshheading:15351399... | lld:pubmed |
pubmed-article:15351399 | pubmed:meshHeading | pubmed-meshheading:15351399... | lld:pubmed |
pubmed-article:15351399 | pubmed:year | 2004 | lld:pubmed |
pubmed-article:15351399 | pubmed:articleTitle | The anandamide membrane transporter. Structure-activity relationships of anandamide and oleoylethanolamine analogs with phenyl rings in the polar head group region. | lld:pubmed |
pubmed-article:15351399 | pubmed:affiliation | Endocannabinoid Research Group, Institute of Biomolecular Chemistry, Consiglio Nazionale delle Ricerche, Via Campi Flegrei 34, 80078 Pozzuoli, Napoli, Italy. | lld:pubmed |
pubmed-article:15351399 | pubmed:publicationType | Journal Article | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15351399 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15351399 | lld:pubmed |